NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD
Focusing on advancing body contouring by providing the first all-in-one platform for the surgical suite...
CLEARWATER, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a...
CLEARWATER, Fla., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a...
CLEARWATER, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical” or the “Company”), the manufacturer of a...
Strengthened balance sheet with a common stock registered direct offering with gross proceeds of approximately $7.0 million; and amended revenue covenants...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apyx Medical (NASDAQ:APYX) just reported results for the second quarter of 2024...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apyx Medical (NASDAQ:APYX) just reported results for the fourth quarter of 2023...
CLEARWATER, Fla., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Apyx® Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a...
/PRNewswire/ -- Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), a leader in advanced energy technology and the manufacturer of...
APYX stock results show that Apyx Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
/PRNewswire/ -- Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), the manufacturer of a proprietary helium plasma and radiofrequency...
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
APYX stock results show that Apyx Medical missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Apyx Medical (APYX) stock rose after the company announced publication a safety analysis in a peer-reviewed journal for its product Reunvion following liposuction. Read more here.
Apyx Medical's CFO, Matthew Hill, purchased 2.5K common shares at $2.19/share, as company shares rose 3.8% on Thursday.
Apyx Medical appoints Matthew Hill as CFO, replacing Tara Semb.